Merck & Co. posted a $1.63 billion fourth-quarter loss Wednesday as a whopping charge for its Vioxx litigation settlement dragged down results.
Merck & Co. will seek regulatory approval for new cholesterol and obesity drugs next year and the pharmaceutical company said Tuesday that five other drugs are undergoing final human testing.
The drugmaker Merck & Co. on Tuesday offered profit forecasts for this year and next that fell short of Wall Street expectations, sending its shares lower.
Merck & Co. posted a 62 percent increase in its third-quarter profit Monday, as the drugmaker's revenues increased by double digits. It also boosted its full-year earnings forecast. Its shares rose more than 2 percent.
An experimental cholesterol treatment touted by drugmaker Merck & Co. significantly reduced artery-clogging fats in late-stage testing, but it got a mixed reception from Wall Street analysts Tuesday.
Pediatricians, gynecologists and even health insurers all call Gardasil, the first vaccine to prevent cervical cancer, a big medical advance.
Pfizer Inc., struggling with fierce competition from makers of generic drugs, announced Monday it will cut 10,000 jobs and close at least five facilities as part of an effort to slash its annual costs by up to $2 billion by the end of next year.
Pharmaceutical company Merck & Co. said Monday it agreed to pay an eye-popping $1.1 billion to buy Sirna Therapeutics Inc., a tiny biotechnology firm developing drugs based on new technology at the heart of last month's Nobel Prize for medicine award.
German drug maker Merck KGaA said Friday it is dropping development of a new Parkinson's disease treatment after Phase III clinical trials failed to confirm the results of previous studies.
Findings indicate HPV is the new leader in causes of oral cancer.
The HPV virus now causes as many cancers of the upper throat as tobacco and alcohol, probably due both to an increase in oral sex and the decline in smoking, researchers say.
A cervical cancer jab that is to be given to schoolgirls across the UK may have killed two youngsters. The vaccine is to be rolled out across the UK The vaccine is to be rolled out across the UK
The recent study questioning the efficacy of two popular prescription drugs in reducing disease-causing cholesterol has triggered a strong response by their makers Schering-Plough Corp and Merck & Co.
New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.
The new Merck/Merial Manual for Pet Health: Home Edition (Merck & Company, $22.95), an exhaustive guide to the illnesses and care of many of the species that humans, sensibly or not, have turned to for companionship, aims to help out.
Drug giant Merck agreed to overhaul its disposal system and pay a fine for violating federal and state water pollution laws, the U.S. Justice Department said. The violations occurred at Merck's pharmaceutical plant near Philadelphia.
Prescriptions for the cholesterol-lowering drugs Zetia and Vytorin are written for almost 800,000 Americans every week, at a cost this year of about $4 billion. Yet it still is not clear how well the drugs work.
Thousands of people who volunteered to test an experimental AIDS vaccine that may have actually raised the risk of infection will be told if they got the actual shot, researchers said on Tuesday.
coalition of physicians and scientists are petitioning the Food and Drug Administration (FDA) to push the agency to stem what the coalition says are dangerous drugs reaching American consumers by mandating the use of scientifically superior non-animal testing methods when those …
Infection rates increase in some trial participants.
Volunteers in a failed worldwide AIDS-vaccine study headed by Seattle researchers will be told whether they were given the experimental vaccine — and may face a higher risk of getting HIV than those who got a placebo.
But drug firm maintains it was not at fault over arthritis drug.
There's another story on the front page of record settlement paid by Merck for deadly effects of the Vioxx.
Three years after withdrawing its pain medication Vioxx from the market, Merck announced today that it will pay $4.85 billion to settle 27,000 lawsuits by people who contend they or their family members suffered injury or died after taking the drug.
That's why we at FOX Business decided to cobble together the FOX 50 (FOX50), an index of the largest U.S. companies that make the products you know and use every day. Think of it as the stock index of your life.
These are fantabulous interactive maps showing exactly how the drugs are moving and what a joke claims of a war on drugs, really is.
On Wednesday, September, 5, 2007 by Judith Siers-Poisson
...Emily's story is only one of 1,637 complaints involving Gardasil, filed as of May to the Vaccine Adverse Event Reporting System (VAERS), a national surveillance database sponsored by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC …
As corporate interests increasingly replace consumer protections in America it is essential to find independent sources to do what MSM ought to, but does not in an endless quest for advertising dollars.
Gardasil, the Merck drug aimed at preventing HPV (and, thus, cervical cancer) — which you'll remember was mandated as a required immunization for Texas girls by governor Rick Perry (and wisely overturned by the Texas legislature) — is looking not to be the safest of vaccines: …
Girls will be given jabs to protect them from cervical cancer at the age of 12 or 13 from next year, ministers announced today.
Merck & Co., the drugmaker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its drug Fosamax may damage jaw bones, a law firm said.
he maker of osteoporosis drug Fosamax is facing a class-action lawsuit amid allegations the drug causes a condition known as "jaw death." The law firm Siskinds LLP has launched the suit against Merck Frosst Canada.
Rejects Bush administration pressure and issues compulsory license on important AIDS drug